Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey
- 18 February 2010
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 39 (4), 303-309
- https://doi.org/10.3109/03009740903468982
Abstract
Objectives: To compare the Psoriatic Arthritis Quality of Life (PsAQoL) instrument, the Health Assessment Questionnaire (HAQ) as a measure of functional status, and the generic health status (utility) measure the EuroQoL (EQ-5D) in terms of ability to assess disease severity in psoriatic arthritis (PsA). Methods: The differences between known groups and correlations of the PsAQoL, the HAQ and the EQ-5D with clinical measures were analysed in a sample of 183 PsA patients. Results: Different severities of PsA determined by known groups were distinguished well by all three questionnaires; more severe disease was associated with significantly worse values of the instruments. The correlations revealed a strong relationship between each of the measures, and with the patients’ pain on the visual analogue scale (VAS), the patient global VAS, and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and a weak relationship with the disease duration and the Psoriasis Area Severity Index (PASI). The PsAQoL also correlated strongly with the 28-joint Disease Activity Score (DAS28). Conclusions: The PsAQoL, the HAQ, and the EQ-5D are able to distinguish well across levels of PsA severity.Keywords
This publication has 13 references indexed in Scilit:
- Comparison of work disability and health‐related quality of life between males and females with rheumatoid arthritis below the age of 45 yearsScandinavian Journal of Rheumatology, 2009
- Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6?month course of TNF inhibitors: prospective intervention study and partial economic evaluationScandinavian Journal of Rheumatology, 2009
- The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritisRheumatology, 2007
- Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritisAnnals Of The Rheumatic Diseases, 2007
- Cultural adaptation of quality of life measures.Scandinavian Journal of Rheumatology, 2007
- An Overview of Economic Evaluations for Drugs Used in Rheumatoid ArthritisDrugs, 2005
- EQ-5D concepts and methods: A developmental historyPublished by Springer Nature ,2005
- Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritisAnnals Of The Rheumatic Diseases, 2004
- A comparison of the EQ‐5D and SF‐6D across seven patient groupsHealth Economics, 2004
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978